BIB
Ultra Nasdaq Biotechnology
Investment Objective
ProShares Ultra Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®.
View all
Fund detail sections
Documents & Downloads
You may order paper copies by contacting ProShares Client Services at 866-PRO-5125 (866-776-5125)
Performance
Daily Return during Q2 2024
Chart is updated nightly to reflect the more recent of the previous day's market closing price or the closing price on the day the fund was last traded.
Total Return
Month-End Total Returns as of 3/31/2024
| Fund | 1m | 3m | 6m | YTD | 1Y | 3Y | 5Y | 10Y | Since Inception | Inception Date |
|---|---|---|---|---|---|---|---|---|---|---|
| BIB Market Price | -0.38% | 0.93% | 20.13% | 0.93% | 6.36% | -11.66% | 0.77% | 3.74% | 15.72% | 04/07/2010 |
| BIB NAV | -0.40% | 0.82% | 19.90% | 0.82% | 6.23% | -11.64% | 0.79% | 3.73% | 15.72% | 04/07/2010 |
| Fund | 1m | 3m | 6m | YTD | 1Y | 3Y | 5Y | 10Y | Since Inception | Inception Date |
|---|---|---|---|---|---|---|---|---|---|---|
| BIB Market Price | -0.38% | 0.93% | 20.13% | 0.93% | 6.36% | -11.66% | 0.77% | 3.74% | 15.72% | 04/07/2010 |
| BIB NAV | -0.40% | 0.82% | 19.90% | 0.82% | 6.23% | -11.64% | 0.79% | 3.73% | 15.72% | 04/07/2010 |
The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.
About the Fund
Snapshot
- Ticker BIB
- Intraday Ticker BIB.IV
- CUSIP 74347R214
- Inception Date 4/7/10
- Gross Expense Ratio 1.15%
- Net Expense Ratio 0.95%
- NAV Calculation Time 4:00 p.m. ET
- Distributions Quarterly
Price
as of 4/25/2024- NAV $48.86
- NAV Change $-1.27
- Market Price $48.94
- Market Price Change $-1.18
- Trading Volume (M) 28,235
- 30-Day Median Bid Ask Spread 0.00%
- View Premium / Discount
Snapshot
- Ticker BIB
- Intraday Ticker BIB.IV
- CUSIP 74347R214
- Inception Date 4/7/10
- Expense Ratio 0.95%
- Gross Expense Ratio 1.15%
- NAV Calculation Time 4:00 p.m. ET
- Distributions Quarterly
Price
as of 4/25/2024- NAV $48.86
- NAV Change $-1.27
- Market Price $48.94
- Market Price Change $-1.18
- Trading Volume (M) 28,235
- 30-Day Median Bid Ask Spread 0.00%
- View Premium / Discount
The expense ratio above has a contractual waiver ending 9/30/24.
Exposures
Index as of 3/28/2024
Holdings
as of 4/25/2024
| Exposure Weight | Ticker | Description | Exposure Value (Notional + GL) |
Market Value | Shares/Contracts | SEDOL Number |
|---|---|---|---|---|---|---|
| 37.81% | -- | NASDAQ BIO INDEX SWAP BNP | 30,019,091 | -- | 7,326 | -- |
| 37.11% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG | 29,461,816 | -- | 7,190 | -- |
| 20.09% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA | 15,951,996 | -- | 3,893 | -- |
| 15.15% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE | 12,030,583 | -- | 2,936 | -- |
| 6.82% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL | 5,412,943 | -- | 1,321 | -- |
| 6.37% | AMGN | AMGEN INC | -- | $5,060,303.30 | 18,785 | 2023607 |
| 6.12% | VRTX | VERTEX PHARMACEUTICALS INC | -- | $4,862,280.20 | 12,226 | 2931034 |
| 5.97% | REGN | REGENERON PHARMACEUTICALS | -- | $4,743,761.68 | 5,326 | 2730190 |
| 5.86% | GILD | GILEAD SCIENCES INC | -- | $4,656,557.61 | 71,343 | 2369174 |
| 5.38% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA | 4,269,710 | -- | 1,042 | -- |
| 3.61% | AZN | ASTRAZENECA PLC-SPONS ADR | -- | $2,868,922.11 | 38,237 | 2989044 |
| 3.52% | -- | NASDAQ BIOTECHNOLOGY INDEX SWAP MORGAN STANLEY & CO. INTERNATIONAL PLC | 2,798,668 | -- | 683 | -- |
| 3.36% | MRNA | MODERNA INC | -- | $2,664,162.38 | 25,091 | BGSXTS3 |
| 2.43% | BIIB | BIOGEN INC | -- | $1,932,480.70 | 9,545 | 2455965 |
| 1.59% | ILMN | ILLUMINA INC | -- | $1,262,914.65 | 10,433 | 2613990 |
| 1.50% | ALNY | ALNYLAM PHARMACEUTICALS INC | -- | $1,188,769.12 | 8,272 | B00FWN1 |
| 1.28% | BMRN | BIOMARIN PHARMACEUTICAL INC | -- | $1,017,839.79 | 12,387 | 2437071 |
| 1.13% | NBIX | NEUROCRINE BIOSCIENCES INC | -- | $900,537.12 | 6,537 | 2623911 |
| 1.13% | VTRS | VIATRIS INC | -- | $894,430.60 | 77,980 | BMWS3X9 |
| 1.12% | SNY | SANOFI-ADR | -- | $887,887.68 | 17,988 | 2964557 |
| 1.04% | RPRX | ROYALTY PHARMA PLC- CL A | -- | $824,578.74 | 29,334 | BMVP7Y0 |
| 0.99% | MEDP | MEDPACE HOLDINGS INC | -- | $787,725.17 | 2,021 | BDCBC61 |
| 0.99% | SRPT | SAREPTA THERAPEUTICS INC | -- | $785,231.96 | 6,164 | B8DPDT7 |
| 0.95% | INCY | INCYTE CORP | -- | $754,700.28 | 14,746 | 2471950 |
| 0.95% | ARGX | ARGENX SE - ADR | -- | $753,049.80 | 2,043 | BDVLM39 |
| 0.92% | UTHR | UNITED THERAPEUTICS CORP | -- | $729,557.40 | 3,092 | 2430412 |
| 0.73% | ROIV | ROIVANT SCIENCES LTD | -- | $575,726.08 | 52,916 | BMW4NZ9 |
| 0.69% | BNTX | BIONTECH SE-ADR | -- | $551,128.76 | 6,356 | BK6H543 |
| 0.65% | ASND | ASCENDIS PHARMA A/S - ADR | -- | $516,636.89 | 3,773 | BV9G6B8 |
| 0.59% | EXEL | EXELIXIS INC | -- | $468,505.83 | 19,911 | 2576941 |
| 0.58% | ITCI | INTRA-CELLULAR THERAPIES INC | -- | $458,746.80 | 6,360 | BHCB0P4 |
| 0.55% | JAZZ | JAZZ PHARMACEUTICALS PLC | -- | $439,603.56 | 4,092 | B4Q5ZN4 |
| 0.55% | CYTK | CYTOKINETICS INC | -- | $438,112.80 | 6,761 | BBBSBJ5 |
| 0.54% | PCVX | VAXCYTE INC | -- | $427,386.96 | 7,116 | BKPVGH6 |
| 0.51% | BGNE | BEIGENE LTD-ADR | -- | $403,934.64 | 2,719 | BYYWPW6 |
| 0.50% | IONS | IONIS PHARMACEUTICALS INC | -- | $400,576.16 | 9,574 | BDJ0LS6 |
| 0.48% | RVMD | REVOLUTION MEDICINES INC | -- | $382,164.61 | 10,817 | BL71K91 |
| 0.48% | APLS | APELLIS PHARMACEUTICALS INC | -- | $379,653.53 | 7,921 | BYTQ6X1 |
| 0.46% | BPMC | BLUEPRINT MEDICINES CORP | -- | $364,916.06 | 4,022 | BWY52P3 |
| 0.40% | HALO | HALOZYME THERAPEUTICS INC | -- | $320,217.96 | 8,326 | 2975098 |
| 0.36% | KRYS | KRYSTAL BIOTECH INC | -- | $288,942.08 | 1,856 | BD6JX35 |
| 0.36% | CRSP | CRISPR THERAPEUTICS AG | -- | $283,264.56 | 5,272 | BDHF4K6 |
| 0.35% | BBIO | BRIDGEBIO PHARMA INC | -- | $280,889.85 | 11,545 | BK1KWG8 |
| 0.35% | ALPN | ALPINE IMMUNE SCIENCES INC | -- | $278,253.72 | 4,306 | BYX38M1 |
| 0.34% | ALKS | ALKERMES PLC | -- | $268,106.80 | 10,970 | B3P6D26 |
| 0.33% | IMVT | IMMUNOVANT INC | -- | $264,735.00 | 9,540 | BJRFSB7 |
| 0.32% | NUVL | NUVALENT INC-A | -- | $254,501.64 | 3,852 | BMVBZD3 |
| 0.32% | MDGL | MADRIGAL PHARMACEUTICALS INC | -- | $254,249.04 | 1,308 | BD59BS7 |
| 0.31% | INSM | INSMED INC | -- | $242,920.16 | 9,748 | 2614487 |
| 0.30% | RARE | ULTRAGENYX PHARMACEUTICAL IN | -- | $237,140.80 | 5,408 | BJ62Z18 |
| 0.29% | LEGN | LEGEND BIOTECH CORP-ADR | -- | $232,494.28 | 5,234 | BMX9K07 |
| 0.28% | IBRX | IMMUNITYBIO INC | -- | $224,037.73 | 43,843 | BNSP0B8 |
| 0.28% | AXSM | AXSOME THERAPEUTICS INC | -- | $222,355.68 | 3,109 | BYZR4X4 |
| 0.27% | SWTX | SPRINGWORKS THERAPEUTICS INC | -- | $214,060.60 | 4,843 | BGMGM89 |
| 0.27% | FTRE | FORTREA HOLDINGS INC | -- | $211,884.15 | 5,829 | BRXYZ57 |
| 0.27% | IOVA | IOVANCE BIOTHERAPEUTICS INC | -- | $211,655.14 | 18,341 | BF0DMK7 |
| 0.25% | XENE | XENON PHARMACEUTICALS INC | -- | $198,615.30 | 4,953 | BRJ3GY4 |
| 0.25% | FOLD | AMICUS THERAPEUTICS INC | -- | $197,247.15 | 19,395 | B19FQ48 |
| 0.24% | CRNX | CRINETICS PHARMACEUTICALS IN | -- | $193,392.17 | 4,573 | BDD19F8 |
| 0.24% | IDYA | IDEAYA BIOSCIENCES INC | -- | $189,006.28 | 4,894 | BK0VHF6 |
| 0.22% | ACLX | ARCELLX INC | -- | $178,031.70 | 3,465 | BPCJ1Q2 |
| 0.22% | ARWR | ARROWHEAD PHARMACEUTICALS IN | -- | $177,978.06 | 8,138 | BYQBFJ8 |
| 0.22% | ACAD | ACADIA PHARMACEUTICALS INC | -- | $176,523.13 | 10,823 | 2713317 |
| 0.22% | MRUS | MERUS NV | -- | $170,823.86 | 3,802 | BZBY005 |
| 0.21% | SMMT | SUMMIT THERAPEUTICS INC | -- | $163,569.80 | 46,076 | BMTVQS7 |
| 0.20% | JANX | JANUX THERAPEUTICS INC | -- | $156,654.60 | 3,326 | BMFX8Y7 |
| 0.19% | RYTM | RHYTHM PHARMACEUTICALS INC | -- | $150,539.90 | 3,946 | BF2YWG4 |
| 0.18% | VCEL | VERICEL CORP | -- | $144,121.95 | 3,171 | BSBMN89 |
| 0.18% | ARVN | ARVINAS INC | -- | $141,315.20 | 4,472 | BDZ30Q0 |
| 0.17% | GH | GUARDANT HEALTH INC | -- | $137,159.88 | 7,993 | BFXC911 |
| 0.17% | DNLI | DENALI THERAPEUTICS INC | -- | $136,689.52 | 9,137 | BD2B4V0 |
| 0.17% | KYMR | KYMERA THERAPEUTICS INC | -- | $133,833.55 | 4,013 | BMPRZV5 |
| 0.17% | VERA | VERA THERAPEUTICS INC | -- | $133,441.81 | 3,449 | BL55460 |
| 0.17% | RCKT | ROCKET PHARMACEUTICALS INC | -- | $131,362.40 | 5,944 | BDFKQ07 |
| 0.17% | IMCR | IMMUNOCORE HOLDINGS PLC-ADR | -- | $131,254.00 | 2,263 | BLCD809 |
| 0.16% | AMPH | AMPHASTAR PHARMACEUTICALS IN | -- | $128,900.31 | 3,157 | BNFWZS4 |
| 0.16% | PTCT | PTC THERAPEUTICS INC | -- | $128,189.21 | 5,029 | B17VCN9 |
| 0.16% | KROS | KEROS THERAPEUTICS INC | -- | $128,050.97 | 2,363 | BM7V485 |
| 0.16% | GERN | GERON CORP | -- | $127,643.80 | 35,855 | 2370381 |
| 0.16% | NTLA | INTELLIA THERAPEUTICS INC | -- | $126,386.26 | 6,313 | BYZM6C2 |
| 0.16% | DYN | DYNE THERAPEUTICS INC | -- | $126,246.96 | 5,328 | BN15WD1 |
| 0.16% | RNA | AVIDITY BIOSCIENCES INC | -- | $124,797.71 | 5,237 | BMWHPY1 |
| 0.16% | GPCR | STRUCTURE THERAPEUTICS INC | -- | $124,580.08 | 3,196 | BQS9486 |
| 0.15% | SANA | SANA BIOTECHNOLOGY INC | -- | $123,063.00 | 14,478 | BMFJJ97 |
| 0.15% | TWST | TWIST BIOSCIENCE CORP | -- | $118,010.76 | 3,797 | BGKG6G7 |
| 0.15% | RXRX | RECURSION PHARMACEUTICALS-A | -- | $116,949.28 | 14,917 | BM9FJ13 |
| 0.15% | AGIO | AGIOS PHARMACEUTICALS INC | -- | $116,798.96 | 3,688 | BCBVTX1 |
| 0.15% | BEAM | BEAM THERAPEUTICS INC | -- | $115,840.80 | 5,363 | BK6L288 |
| 0.14% | SNDX | SYNDAX PHARMACEUTICALS INC | -- | $114,780.60 | 5,580 | BN7Q7R7 |
| 0.14% | APGE | APOGEE THERAPEUTICS INC | -- | $111,898.40 | 2,440 | BM9HHL5 |
| 0.14% | HRMY | HARMONY BIOSCIENCES HOLDINGS | -- | $107,764.25 | 3,725 | BKSGZN7 |
| 0.13% | MYGN | MYRIAD GENETICS INC | -- | $106,135.94 | 5,903 | 2614153 |
| 0.13% | INBX | INHIBRX INC | -- | $106,053.99 | 3,111 | BK1MBC3 |
| 0.13% | SUPN | SUPERNUS PHARMACEUTICALS INC | -- | $105,252.21 | 3,591 | B72ZBG4 |
| 0.13% | -- | AVADEL PHARMACEUTICALS | -- | $105,013.26 | 5,893 | BDGMC59 |
| 0.13% | FUSN | FUSION PHARMACEUTICALS INC | -- | $101,692.80 | 4,752 | BJK0NH0 |
| 0.12% | EWTX | EDGEWISE THERAPEUTICS INC | -- | $97,457.16 | 6,114 | BKY5JZ8 |
| 0.12% | ADMA | ADMA BIOLOGICS INC | -- | $96,503.40 | 14,985 | B9NSBM2 |
| 0.12% | ARDX | ARDELYX INC | -- | $96,429.42 | 15,282 | BN89V40 |
| 0.12% | VCYT | VERACYTE INC | -- | $96,075.36 | 4,932 | BFTWZY0 |
| 0.12% | DVAX | DYNAVAX TECHNOLOGIES CORP | -- | $95,816.26 | 8,578 | BRJZSK0 |
| 0.12% | KURA | KURA ONCOLOGY INC | -- | $95,000.00 | 5,000 | BYZD465 |
| 0.12% | PTGX | PROTAGONIST THERAPEUTICS INC | -- | $94,324.50 | 3,825 | BDCBCD8 |
| 0.12% | MORF | MORPHIC HOLDING INC | -- | $91,886.32 | 3,284 | BK8M4J4 |
| 0.11% | ANIP | ANI PHARMACEUTICALS INC | -- | $89,825.85 | 1,383 | BCDWBX6 |
| 0.11% | NVCR | NOVOCURE LTD | -- | $85,976.90 | 7,030 | BYSS4X4 |
| 0.10% | IRWD | IRONWOOD PHARMACEUTICALS INC | -- | $83,070.48 | 10,281 | B3MZ6K5 |
| 0.10% | LGND | LIGAND PHARMACEUTICALS | -- | $81,840.31 | 1,163 | 2501578 |
| 0.10% | PCRX | PACIRA BIOSCIENCES INC | -- | $77,928.00 | 3,056 | B3X26D8 |
| 0.10% | XNCR | XENCOR INC | -- | $77,169.99 | 4,013 | BGCYWN8 |
| 0.10% | FDMT | 4D MOLECULAR THERAPEUTICS IN | -- | $76,943.10 | 3,270 | BKLXFX5 |
| 0.10% | DAWN | DAY ONE BIOPHARMACEUTICALS I | -- | $75,772.56 | 5,736 | BLB0YH0 |
| 0.10% | GMAB | GENMAB A/S -SP ADR | -- | $75,569.92 | 2,752 | BBC9WC7 |
| 0.09% | COLL | COLLEGIUM PHARMACEUTICAL INC | -- | $75,228.16 | 2,099 | BX7RSN3 |
| 0.09% | DCPH | DECIPHERA PHARMACEUTICALS IN | -- | $75,224.90 | 5,305 | BZ1LFB2 |
| 0.09% | MIRM | MIRUM PHARMACEUTICALS INC | -- | $74,914.91 | 3,059 | BJDX8Y8 |
| 0.09% | MNKD | MANNKIND CORP | -- | $74,224.26 | 17,757 | BF081J4 |
| 0.09% | PRTA | PROTHENA CORP PLC | -- | $72,535.68 | 3,528 | B91XRN2 |
| 0.09% | TARS | TARSUS PHARMACEUTICALS INC | -- | $72,440.29 | 2,249 | BMH5RL1 |
| 0.09% | AKRO | AKERO THERAPEUTICS INC | -- | $69,965.28 | 3,696 | BK7Y2V9 |
| 0.09% | ABCL | ABCELLERA BIOLOGICS INC | -- | $69,786.75 | 19,225 | BL53SR3 |
| 0.09% | VRNA | VERONA PHARMA PLC - ADR | -- | $68,313.22 | 4,462 | BYWPZK5 |
| 0.09% | VIR | VIR BIOTECHNOLOGY INC | -- | $67,639.95 | 8,865 | BK4PZ38 |
| 0.08% | SRRK | SCHOLAR ROCK HOLDING CORP | -- | $66,142.48 | 4,738 | BFZQ0L8 |
| 0.08% | MRVI | MARAVAI LIFESCIENCES HLDGS-A | -- | $65,839.88 | 8,686 | BMCWKZ2 |
| 0.08% | INVA | INNOVIVA INC | -- | $62,238.48 | 4,152 | BDDXF67 |
| 0.07% | MGNX | MACROGENICS INC | -- | $58,557.75 | 4,075 | BFDV8K0 |
| 0.07% | BCRX | BIOCRYST PHARMACEUTICALS INC | -- | $56,322.24 | 13,539 | 2100362 |
| 0.07% | ALXO | ALX ONCOLOGY HOLDINGS INC | -- | $55,215.51 | 3,273 | BLN7XQ1 |
| 0.07% | ARQT | ARCUTIS BIOTHERAPEUTICS INC | -- | $54,632.40 | 6,360 | BKX9VD3 |
| 0.07% | CGEM | CULLINAN ONCOLOGY INC | -- | $54,073.25 | 2,809 | BM90J52 |
| 0.07% | SAGE | SAGE THERAPEUTICS INC | -- | $53,641.00 | 3,950 | BP4GNK9 |
| 0.07% | RLAY | RELAY THERAPEUTICS INC | -- | $53,019.17 | 8,614 | BN2R582 |
| 0.07% | BCYC | BICYCLE THERAPEUTICS PLC-ADR | -- | $52,719.32 | 2,341 | BKDQKM6 |
| 0.07% | EYPT | EYEPOINT PHARMACEUTICALS INC | -- | $51,808.96 | 3,206 | BMGS7L1 |
| 0.06% | ZNTL | ZENTALIS PHARMACEUTICALS INC | -- | $51,212.07 | 4,662 | BMQ5T49 |
| 0.06% | ZLAB | ZAI LAB LTD-ADR | -- | $51,186.48 | 3,252 | BD9GVY0 |
| 0.06% | SPRY | ARS PHARMACEUTICALS INC | -- | $51,007.45 | 6,305 | BMCR7V2 |
| 0.06% | ETNB | 89BIO INC | -- | $50,498.25 | 6,121 | BK1K484 |
| 0.06% | GRFS | GRIFOLS SA-ADR | -- | $50,210.16 | 8,008 | B8K7T65 |
| 0.06% | TNGX | TANGO THERAPEUTICS INC | -- | $49,096.34 | 6,698 | BP2P6L0 |
| 0.06% | PLRX | PLIANT THERAPEUTICS INC | -- | $46,973.52 | 3,954 | BMDWW66 |
| 0.06% | RGNX | REGENXBIO INC | -- | $46,895.20 | 2,920 | BZ0G875 |
| 0.06% | AUPH | AURINIA PHARMACEUTICALS INC | -- | $46,240.65 | 9,495 | BFWLC09 |
| 0.06% | KNSA | KINIKSA PHARMACEUTICALS-A | -- | $46,208.64 | 2,624 | BD0MGM0 |
| 0.06% | ARCT | ARCTURUS THERAPEUTICS HOLDIN | -- | $45,980.69 | 1,757 | BKC9SX3 |
| 0.06% | ELVN | ENLIVEN THERAPEUTICS INC | -- | $45,373.12 | 2,704 | BMFD115 |
| 0.05% | EOLS | EVOLUS INC | -- | $43,009.38 | 3,753 | BDRJH21 |
| 0.05% | YMAB | Y-MABS THERAPEUTICS INC | -- | $42,694.68 | 2,877 | BG31GH0 |
| 0.05% | IRON | DISC MEDICINE INC | -- | $41,954.64 | 1,582 | BMGJZJ8 |
| 0.05% | COGT | COGENT BIOSCIENCES INC | -- | $41,006.23 | 6,823 | BLR6XK8 |
| 0.05% | SIGA | SIGA TECHNOLOGIES INC | -- | $40,314.24 | 4,666 | 2107437 |
| 0.05% | NRIX | NURIX THERAPEUTICS INC | -- | $39,675.60 | 3,210 | BMVLGP2 |
| 0.05% | SVRA | SAVARA INC | -- | $39,551.60 | 8,888 | BYXGN81 |
| 0.05% | HCM | HUTCHMED CHINA-ADR | -- | $38,644.65 | 2,035 | BYXV9H7 |
| 0.05% | WVE | WAVE LIFE SCIENCES LTD | -- | $37,976.88 | 8,012 | BYZG9R0 |
| 0.05% | AUTL | AUTOLUS THERAPEUTICS PLC | -- | $37,711.44 | 9,243 | BFMLGR4 |
| 0.05% | ZYME | ZYMEWORKS INC | -- | $37,281.67 | 4,597 | BPCQZY9 |
| 0.05% | GLPG | GALAPAGOS NV-SPON ADR | -- | $37,104.48 | 1,296 | B292NQ7 |
| 0.05% | LYEL | LYELL IMMUNOPHARMA INC | -- | $36,707.00 | 16,685 | BN6MB18 |
| 0.05% | NVAX | NOVAVAX INC | -- | $36,300.50 | 9,190 | BJDQXG4 |
| 0.04% | OLMA | OLEMA PHARMACEUTICALS INC | -- | $35,564.94 | 3,618 | BMZ4LN0 |
| 0.04% | CSTL | CASTLE BIOSCIENCES INC | -- | $35,215.55 | 1,805 | BKLCWZ3 |
| 0.04% | CABA | CABALETTA BIO INC | -- | $34,274.52 | 2,814 | BK5MWR1 |
| 0.04% | PHAT | PHATHOM PHARMACEUTICALS INC | -- | $34,225.10 | 3,761 | BJLKVS6 |
| 0.04% | VERV | VERVE THERAPEUTICS INC | -- | $34,154.02 | 5,491 | BNKGXX2 |
| 0.04% | CVAC | CUREVAC NV | -- | $33,959.31 | 14,701 | BN4RD42 |
| 0.04% | ORIC | ORIC PHARMACEUTICALS INC | -- | $33,932.08 | 4,424 | BKVDFF7 |
| 0.04% | OABI | OMNIAB INC | -- | $33,814.19 | 7,633 | BN13S71 |
| 0.04% | CNTA | CENTESSA PHARMACEUTICALS-ADR | -- | $33,058.86 | 3,702 | BLB0YQ9 |
| 0.04% | ANAB | ANAPTYSBIO INC | -- | $32,947.02 | 1,746 | BDRW1L7 |
| 0.04% | PRME | PRIME MEDICINE INC | -- | $32,916.50 | 7,655 | BPBJFM7 |
| 0.04% | ALLO | ALLOGENE THERAPEUTICS INC | -- | $31,542.04 | 11,048 | BFZNYB7 |
| 0.04% | PETQ | PETIQ INC | -- | $31,285.44 | 1,917 | BDH65C8 |
| 0.04% | OCUL | OCULAR THERAPEUTIX INC | -- | $30,403.80 | 7,239 | BNZB1X8 |
| 0.04% | ALEC | ALECTOR INC | -- | $30,240.47 | 6,287 | BJ4LDC4 |
| 0.04% | ABUS | ARBUTUS BIOPHARMA CORP | -- | $29,949.92 | 11,011 | BZ0QMB7 |
| 0.04% | TBPH | THERAVANCE BIOPHARMA INC | -- | $29,906.08 | 3,272 | BMNDK09 |
| 0.04% | MLYS | MINERALYS THERAPEUTICS INC | -- | $29,830.08 | 2,702 | BP9N0G0 |
| 0.04% | FULC | FULCRUM THERAPEUTICS INC | -- | $29,004.84 | 4,068 | BJDX8Z9 |
| 0.04% | KALV | KALVISTA PHARMACEUTICALS INC | -- | $28,648.19 | 2,731 | BD06CS0 |
| 0.04% | TSHA | TAYSHA GENE THERAPIES INC | -- | $28,239.40 | 12,278 | BNC1BX1 |
| 0.04% | EDIT | EDITAS MEDICINE INC | -- | $28,057.50 | 5,375 | BZ8FPH3 |
| 0.04% | URGN | UROGEN PHARMA LTD | -- | $28,040.78 | 2,029 | BZ7PJQ1 |
| 0.03% | THRD | THIRD HARMONIC BIO INC | -- | $27,750.38 | 2,653 | BNNPQY8 |
| 0.03% | SLRN | ACELYRIN INC | -- | $27,106.32 | 6,393 | BQPF874 |
| 0.03% | TVTX | TRAVERE THERAPEUTICS INC | -- | $26,933.83 | 4,997 | BLFGJD5 |
| 0.03% | TRML | TOURMALINE BIO INC | -- | $26,912.00 | 1,682 | BQ80NC6 |
| 0.03% | HUMA | HUMACYTE INC | -- | $26,535.60 | 6,804 | BMYTJP4 |
| 0.03% | VYGR | VOYAGER THERAPEUTICS INC | -- | $26,452.30 | 3,565 | BY7RB53 |
| 0.03% | MXCT | MAXCYTE INC | -- | $25,106.76 | 6,804 | BKMQF66 |
| 0.03% | ITOS | ITEOS THERAPEUTICS INC | -- | $24,888.80 | 2,348 | BMWXFT4 |
| 0.03% | ADPT | ADAPTIVE BIOTECHNOLOGIES | -- | $24,860.25 | 9,525 | BJ5FZ74 |
| 0.03% | REPL | REPLIMUNE GROUP INC | -- | $24,802.95 | 4,033 | BDDVW37 |
| 0.03% | LXRX | LEXICON PHARMACEUTICALS INC | -- | $24,678.50 | 16,025 | BWFZX59 |
| 0.03% | BMEA | BIOMEA FUSION INC | -- | $24,520.74 | 2,342 | BNKF6N0 |
| 0.03% | PACB | PACIFIC BIOSCIENCES OF CALIF | -- | $24,283.86 | 17,597 | B4N8MH9 |
| 0.03% | HROW | HARROW INC | -- | $23,040.00 | 2,304 | BHNDW86 |
| 0.03% | PGEN | PRECIGEN INC | -- | $22,885.80 | 16,347 | BKM5C84 |
| 0.03% | CRBU | CARIBOU BIOSCIENCES INC | -- | $21,838.08 | 5,808 | BNYJR68 |
| 0.03% | AMRN | AMARIN CORP PLC -ADR | -- | $21,791.49 | 25,336 | 2301938 |
| 0.03% | AVIR | ATEA PHARMACEUTICALS INC | -- | $20,390.94 | 5,526 | BLN9Z50 |
| 0.03% | ATAI | ATAI LIFE SCIENCES NV | -- | $20,061.52 | 10,903 | BN6M8F1 |
| 0.02% | MGTX | MEIRAGTX HOLDINGS PLC | -- | $19,659.54 | 4,174 | BFYQFJ2 |
| 0.02% | NAUT | NAUTILUS BIOTECHNOLOGY INC | -- | $19,387.40 | 8,215 | BNG1NK8 |
| 0.02% | RVNC | REVANCE THERAPEUTICS INC | -- | $19,055.68 | 5,792 | BJFSR99 |
| 0.02% | TERN | TERNS PHARMACEUTICALS INC | -- | $18,824.48 | 4,057 | BMDJ0C9 |
| 0.02% | ERAS | ERASCA INC | -- | $18,655.24 | 9,923 | BNLYBF3 |
| 0.02% | AVXL | ANAVEX LIFE SCIENCES CORP | -- | $18,275.49 | 5,391 | BYTYP72 |
| 0.02% | RAPT | RAPT THERAPEUTICS INC | -- | $17,596.80 | 2,256 | BK5T6R0 |
| 0.02% | VNDA | VANDA PHARMACEUTICALS INC | -- | $16,916.48 | 3,776 | B12W3P6 |
| 0.02% | PAHC | PHIBRO ANIMAL HEALTH CORP-A | -- | $16,607.40 | 1,335 | BL95N25 |
| 0.02% | VTYX | VENTYX BIOSCIENCES INC | -- | $15,801.52 | 3,892 | BMG99Y1 |
| 0.02% | XERS | XERIS BIOPHARMA HOLDINGS INC | -- | $15,422.40 | 9,072 | BLR7H87 |
| 0.02% | ACIU | AC IMMUNE SA | -- | $14,862.10 | 6,490 | BZC0D70 |
| 0.02% | QURE | UNIQURE NV | -- | $14,273.76 | 3,144 | BJFSR88 |
| 0.02% | CHRS | COHERUS BIOSCIENCES INC | -- | $14,112.16 | 7,312 | BRK0149 |
| 0.02% | OVID | OVID THERAPEUTICS INC | -- | $13,876.59 | 4,641 | BYPFK63 |
| 0.02% | EXAI | EXSCIENTIA PLC | -- | $12,640.32 | 3,168 | BP48134 |
| 0.01% | -- | ACHILLION PHARMACEUTICALS INC - CVR | -- | $11,641.22 | 25,307 | -- |
| 0.01% | BLUE | BLUEBIRD BIO INC | -- | $11,407.16 | 12,501 | BBFL7S1 |
| 0.01% | ME | 23ANDME HOLDING CO -CLASS A | -- | $9,508.19 | 20,715 | BM9CKX3 |
| 0.01% | AMLX | AMYLYX PHARMACEUTICALS INC | -- | $7,919.22 | 4,449 | BPCK358 |
| 0.01% | ACRS | ACLARIS THERAPEUTICS INC | -- | $5,545.40 | 4,660 | BYV2W40 |
| 0.01% | MRNS | MARINUS PHARMACEUTICALS INC | -- | $5,090.70 | 3,585 | BM8MVZ3 |
| -- | RPHM | RENEO PHARMACEUTICALS INC | -- | $3,610.20 | 2,188 | BMHR7T5 |
| -- | 2324462D | CARTESIAN THERAPEUTICS-CVR | -- | $1,761.30 | 9,785 | BM9HFX3 |
| -- | -- | TREASURY BILL | -- | $14,773,727.85 | 15,000,000 | BRYQ9Y9 |
| -- | -- | NET OTHER ASSETS (LIABILITIES) | -- | $5,908,414.02 | 5,908,414 | -- |
Index
as of 3/28/2024
- Total Number of Companies218
- Price/Earnings Ratio--
- Price/Book Ratio4.157
- Dividend Yield ( % )0.88
- Avg. Index Market Capitalization$6.77 billion
About the Index
The Nasdaq Biotechnology Index is a modified capitalization weighted index that includes securities of The Nasdaq Stock Market listed companies that are classified as either biotechnology or pharmaceutical. The securities also meet other eligibility criteria determined by The Nasdaq OMX Group, Inc., including minimum market capitalization and liquidity requirements.
Distributions
For
2024
- 2024
- 2023
- 2022
| Ex-Dividend Date | Record Date | Payable Date | Dividend | Long-Term Capital Gain | Short-Term Capital Gain | Return of Capital |
|---|
Portfolio Hedging Series
Part I: The Significance of Portfolio Hedging
Investing involves risk. Market downturns will happen. Having a sound investment strategy can help smooth out the turbulence in your portfolio and save you from getting caught up in a herd mentality of selling low into a down market.
Read More